479 related articles for article (PubMed ID: 20388321)
21. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
22. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One.
Carrillo-Muñoz AJ; Quindós G; Ruesga M; del Valle O; Pemán J; Cantón E; Hernández-Molina JM; Santos P
Mycoses; 2006 Jul; 49(4):293-7. PubMed ID: 16784443
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
24. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
Claudino AL; Peixoto RF; Melhem MS; Szeszs MW; Lyon JP; Chavasco JK; Franco MC
Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388
[TBL] [Abstract][Full Text] [Related]
25. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.
Iqbal NJ; Boey A; Park BJ; Brandt ME
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):348-50. PubMed ID: 18707841
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
Garcia-Effron G; Gomez-Lopez A; Mellado E; Monzon A; Rodriguez-Tudela JL; Cuenca-Estrella M
J Antimicrob Chemother; 2004 Jun; 53(6):1086-9. PubMed ID: 15102749
[TBL] [Abstract][Full Text] [Related]
27. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
[TBL] [Abstract][Full Text] [Related]
28. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China.
Xie L; Zhai H; Zhao J; Sun S; Shi W; Dong X
Am J Ophthalmol; 2008 Aug; 146(2):260-265. PubMed ID: 18547535
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan.
Yamazaki T; Inagaki Y; Fujii T; Ohwada J; Tsukazaki M; Umeda I; Kobayashi K; Shimma N; Page MG; Arisawa M
Int J Antimicrob Agents; 2010 Oct; 36(4):324-31. PubMed ID: 20674282
[TBL] [Abstract][Full Text] [Related]
30. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Yüksekkaya S; Fındık D; Arslan U
Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
[TBL] [Abstract][Full Text] [Related]
31. In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
Venturini TP; Rossato L; Spader TB; Tronco-Alves GR; Azevedo MI; Weiler CB; Santurio JM; Alves SH
Diagn Microbiol Infect Dis; 2011 Oct; 71(2):126-30. PubMed ID: 21840673
[TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of amphotericin-B pimaricin and gentian violet on ocular fungi.
Lavingia B; Dave S
Indian J Ophthalmol; 1986; 34():73-7. PubMed ID: 3155339
[No Abstract] [Full Text] [Related]
34. In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006).
Ledbetter EC; Patten VH; Scarlett JM; Vermeylen FM
J Am Vet Med Assoc; 2007 Oct; 231(7):1086-91. PubMed ID: 17916036
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
36. In-vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of amphotericin B, fluconazole and ketoconazole against ocular fungal isolates.
Therese KL; Bagyalakshmi R; Madhavan HN; Deepa P
Indian J Med Microbiol; 2006 Oct; 24(4):273-9. PubMed ID: 17185846
[TBL] [Abstract][Full Text] [Related]
37. [Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method].
Carrillo-Muñoz AJ; Quindós G; Ruesga M; Brió S; del Valle O; Rodríguez V; Hernández-Molina JM; Cantón E; Pemán J; Santos P
Rev Esp Quimioter; 2001 Sep; 14(3):281-5. PubMed ID: 11753450
[TBL] [Abstract][Full Text] [Related]
38. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
Lalitha P; Sun CQ; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Cevallos V; McLeod SD; Acharya NR; Lietman TM;
Am J Ophthalmol; 2014 Feb; 157(2):318-26. PubMed ID: 24439440
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
Favel A; Michel-Nguyen A; Datry A; Challier S; Leclerc F; Chastin C; Fallague K; Regli P
J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility of Mexican isolates of yeasts and moulds to amphotericin B and triazole antifungals.
Arredondo-García JL; Amábile-Cuevas CF;
J Infect Dev Ctries; 2009 Jun; 3(5):398-401. PubMed ID: 19759511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
